Common use of Commercial Milestones Clause in Contracts

Commercial Milestones. In partial consideration of the rights granted by MedImmune to Licensee hereunder, Licensee shall pay to MedImmune the following payments, which shall be nonrefundable, noncreditable and fully earned upon the achievement of the applicable milestone event: (i) Licensee shall pay to MedImmune [***] in the event that the [***]; (ii) Licensee shall pay to MedImmune [***] in the event that the [***]; (iii) Licensee shall pay to MedImmune [***] in the event that the [***]; (iv) Licensee shall pay to MedImmune [***] in the event that the [***]; (v) Licensee shall pay to MedImmune [***] in the event that the [***]; (vi) Licensee shall pay to MedImmune [***] in the event that the [***]; (vii) Licensee shall pay to MedImmune [***] in the event that the [***]; and (viii) Licensee shall pay to MedImmune [***] in the event that [***]. Each such milestone payment shall be due within [***] days of the end of the Calendar Quarter in such Calendar Year in which such milestone was achieved. In the event that in [***]. Each milestone payment in this Section 5.2.2 shall be payable only upon the first achievement of such milestone in a given Calendar Year and no amounts shall be due for subsequent or repeated achievements of such milestone in subsequent Calendar Years.

Commercial Milestones. In partial consideration of the rights granted by MedImmune to Licensee hereunder, Licensee shall pay to MedImmune the following payments, which shall be nonrefundable, noncreditable and fully earned upon the achievement of the applicable milestone event: (i) Licensee shall pay to MedImmune [***] in the event that the [***]; (ii) Licensee shall pay to MedImmune [***] in the event that the [***]; (iii) Licensee shall pay to MedImmune [***] in the event that the [***]; (iv) Licensee shall pay to MedImmune [***] in the event that the [***]; (v) Licensee shall pay to MedImmune [***] in the event that the [***]; (vi) Licensee shall pay to MedImmune [***] in the event that the [***]; (vii) Licensee shall pay to MedImmune [***] in the event that the [***]; and (viii) Licensee shall pay to MedImmune [***] in the event that [***]. Each such milestone payment shall be due within [***] days of the end of the Calendar Quarter in such Calendar Year in which such milestone was achieved. In the event that in [***]. Each milestone payment in this Section 5.2.2 shall be payable only upon the first achievement of such milestone in a given Calendar Year and no amounts shall be due for subsequent or repeated achievements of such milestone in subsequent Calendar Years.. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Confidential Treatment Requested by Kiniksa Pharmaceuticals, Ltd.